Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Inactivated Influenza Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Inactivated Influenza Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Inactivated Influenza Vaccine Overall Market Size
2.1 Global Inactivated Influenza Vaccine Market Size: 2022 VS 2035
2.2 Global Inactivated Influenza Vaccine Revenue, Prospects & Forecasts: 2018-2035
2.3 Global Inactivated Influenza Vaccine Sales: 2018-2035
3 Company Landscape
3.1 Top Inactivated Influenza Vaccine Players in Global Market
3.2 Top Global Inactivated Influenza Vaccine Companies Ranked by Revenue
3.3 Global Inactivated Influenza Vaccine Revenue by Companies
3.4 Global Inactivated Influenza Vaccine Sales by Companies
3.5 Global Inactivated Influenza Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Inactivated Influenza Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Inactivated Influenza Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Inactivated Influenza Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Inactivated Influenza Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Inactivated Influenza Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Inactivated Influenza Vaccine Market Size Markets, 2022 & 2035
4.1.2 Trivalent Influenza Vaccine
4.1.3 Quadrivalent Influenza Vaccine
4.2 By Type - Global Inactivated Influenza Vaccine Revenue & Forecasts
4.2.1 By Type - Global Inactivated Influenza Vaccine Revenue, 2018-2023
4.2.2 By Type - Global Inactivated Influenza Vaccine Revenue, 2024-2035
4.2.3 By Type - Global Inactivated Influenza Vaccine Revenue Market Share, 2018-2035
4.3 By Type - Global Inactivated Influenza Vaccine Sales & Forecasts
4.3.1 By Type - Global Inactivated Influenza Vaccine Sales, 2018-2023
4.3.2 By Type - Global Inactivated Influenza Vaccine Sales, 2024-2035
4.3.3 By Type - Global Inactivated Influenza Vaccine Sales Market Share, 2018-2035
4.4 By Type - Global Inactivated Influenza Vaccine Price (Manufacturers Selling Prices), 2018-2035
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Inactivated Influenza Vaccine Market Size, 2022 & 2035
5.1.2 Children
5.1.3 Adolescence
5.1.4 Adults
5.1.5 Elderly
5.2 By Application - Global Inactivated Influenza Vaccine Revenue & Forecasts
5.2.1 By Application - Global Inactivated Influenza Vaccine Revenue, 2018-2023
5.2.2 By Application - Global Inactivated Influenza Vaccine Revenue, 2024-2035
5.2.3 By Application - Global Inactivated Influenza Vaccine Revenue Market Share, 2018-2035
5.3 By Application - Global Inactivated Influenza Vaccine Sales & Forecasts
5.3.1 By Application - Global Inactivated Influenza Vaccine Sales, 2018-2023
5.3.2 By Application - Global Inactivated Influenza Vaccine Sales, 2024-2035
5.3.3 By Application - Global Inactivated Influenza Vaccine Sales Market Share, 2018-2035
5.4 By Application - Global Inactivated Influenza Vaccine Price (Manufacturers Selling Prices), 2018-2035
6 Sights by Region
6.1 By Region - Global Inactivated Influenza Vaccine Market Size, 2022 & 2035
6.2 By Region - Global Inactivated Influenza Vaccine Revenue & Forecasts
6.2.1 By Region - Global Inactivated Influenza Vaccine Revenue, 2018-2023
6.2.2 By Region - Global Inactivated Influenza Vaccine Revenue, 2024-2035
6.2.3 By Region - Global Inactivated Influenza Vaccine Revenue Market Share, 2018-2035
6.3 By Region - Global Inactivated Influenza Vaccine Sales & Forecasts
6.3.1 By Region - Global Inactivated Influenza Vaccine Sales, 2018-2023
6.3.2 By Region - Global Inactivated Influenza Vaccine Sales, 2024-2035
6.3.3 By Region - Global Inactivated Influenza Vaccine Sales Market Share, 2018-2035
6.4 North America
6.4.1 By Country - North America Inactivated Influenza Vaccine Revenue, 2018-2035
6.4.2 By Country - North America Inactivated Influenza Vaccine Sales, 2018-2035
6.4.3 US Inactivated Influenza Vaccine Market Size, 2018-2035
6.4.4 Canada Inactivated Influenza Vaccine Market Size, 2018-2035
6.4.5 Mexico Inactivated Influenza Vaccine Market Size, 2018-2035
6.5 Europe
6.5.1 By Country - Europe Inactivated Influenza Vaccine Revenue, 2018-2035
6.5.2 By Country - Europe Inactivated Influenza Vaccine Sales, 2018-2035
6.5.3 Germany Inactivated Influenza Vaccine Market Size, 2018-2035
6.5.4 France Inactivated Influenza Vaccine Market Size, 2018-2035
6.5.5 U.K. Inactivated Influenza Vaccine Market Size, 2018-2035
6.5.6 Italy Inactivated Influenza Vaccine Market Size, 2018-2035
6.5.7 Russia Inactivated Influenza Vaccine Market Size, 2018-2035
6.5.8 Nordic Countries Inactivated Influenza Vaccine Market Size, 2018-2035
6.5.9 Benelux Inactivated Influenza Vaccine Market Size, 2018-2035
6.6 Asia
6.6.1 By Region - Asia Inactivated Influenza Vaccine Revenue, 2018-2035
6.6.2 By Region - Asia Inactivated Influenza Vaccine Sales, 2018-2035
6.6.3 China Inactivated Influenza Vaccine Market Size, 2018-2035
6.6.4 Japan Inactivated Influenza Vaccine Market Size, 2018-2035
6.6.5 South Korea Inactivated Influenza Vaccine Market Size, 2018-2035
6.6.6 Southeast Asia Inactivated Influenza Vaccine Market Size, 2018-2035
6.6.7 India Inactivated Influenza Vaccine Market Size, 2018-2035
6.7 South America
6.7.1 By Country - South America Inactivated Influenza Vaccine Revenue, 2018-2035
6.7.2 By Country - South America Inactivated Influenza Vaccine Sales, 2018-2035
6.7.3 Brazil Inactivated Influenza Vaccine Market Size, 2018-2035
6.7.4 Argentina Inactivated Influenza Vaccine Market Size, 2018-2035
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Inactivated Influenza Vaccine Revenue, 2018-2035
6.8.2 By Country - Middle East & Africa Inactivated Influenza Vaccine Sales, 2018-2035
6.8.3 Turkey Inactivated Influenza Vaccine Market Size, 2018-2035
6.8.4 Israel Inactivated Influenza Vaccine Market Size, 2018-2035
6.8.5 Saudi Arabia Inactivated Influenza Vaccine Market Size, 2018-2035
6.8.6 UAE Inactivated Influenza Vaccine Market Size, 2018-2035
7 Manufacturers & Brands Profiles
7.1 CSL Limited
7.1.1 CSL Limited Company Summary
7.1.2 CSL Limited Business Overview
7.1.3 CSL Limited Inactivated Influenza Vaccine Major Product Offerings
7.1.4 CSL Limited Inactivated Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 CSL Limited Key News & Latest Developments
7.2 GSK
7.2.1 GSK Company Summary
7.2.2 GSK Business Overview
7.2.3 GSK Inactivated Influenza Vaccine Major Product Offerings
7.2.4 GSK Inactivated Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 GSK Key News & Latest Developments
7.3 Sanofi Pasteur
7.3.1 Sanofi Pasteur Company Summary
7.3.2 Sanofi Pasteur Business Overview
7.3.3 Sanofi Pasteur Inactivated Influenza Vaccine Major Product Offerings
7.3.4 Sanofi Pasteur Inactivated Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 Sanofi Pasteur Key News & Latest Developments
7.4 Viatris
7.4.1 Viatris Company Summary
7.4.2 Viatris Business Overview
7.4.3 Viatris Inactivated Influenza Vaccine Major Product Offerings
7.4.4 Viatris Inactivated Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 Viatris Key News & Latest Developments
7.5 Hualan Biological
7.5.1 Hualan Biological Company Summary
7.5.2 Hualan Biological Business Overview
7.5.3 Hualan Biological Inactivated Influenza Vaccine Major Product Offerings
7.5.4 Hualan Biological Inactivated Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 Hualan Biological Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Company Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Inactivated Influenza Vaccine Major Product Offerings
7.6.4 AstraZeneca Inactivated Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 AstraZeneca Key News & Latest Developments
7.7 Sinovac Biotech
7.7.1 Sinovac Biotech Company Summary
7.7.2 Sinovac Biotech Business Overview
7.7.3 Sinovac Biotech Inactivated Influenza Vaccine Major Product Offerings
7.7.4 Sinovac Biotech Inactivated Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 Sinovac Biotech Key News & Latest Developments
7.8 Aleph Biomedical
7.8.1 Aleph Biomedical Company Summary
7.8.2 Aleph Biomedical Business Overview
7.8.3 Aleph Biomedical Inactivated Influenza Vaccine Major Product Offerings
7.8.4 Aleph Biomedical Inactivated Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.8.5 Aleph Biomedical Key News & Latest Developments
7.9 Abbott Laboratories
7.9.1 Abbott Laboratories Company Summary
7.9.2 Abbott Laboratories Business Overview
7.9.3 Abbott Laboratories Inactivated Influenza Vaccine Major Product Offerings
7.9.4 Abbott Laboratories Inactivated Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.9.5 Abbott Laboratories Key News & Latest Developments
7.10 Novartis International
7.10.1 Novartis International Company Summary
7.10.2 Novartis International Business Overview
7.10.3 Novartis International Inactivated Influenza Vaccine Major Product Offerings
7.10.4 Novartis International Inactivated Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.10.5 Novartis International Key News & Latest Developments
8 Global Inactivated Influenza Vaccine Production Capacity, Analysis
8.1 Global Inactivated Influenza Vaccine Production Capacity, 2018-2035
8.2 Inactivated Influenza Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Inactivated Influenza Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Inactivated Influenza Vaccine Supply Chain Analysis
10.1 Inactivated Influenza Vaccine Industry Value Chain
10.2 Inactivated Influenza Vaccine Upstream Market
10.3 Inactivated Influenza Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Inactivated Influenza Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer